Switch to:
More From Other Websites
RXI PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination... Dec 19 2014
7:07 am RXi Pharma announces assignment and exclusive global license agreement with Hapten... Dec 19 2014
RXi Pharmaceuticals Expands its Clinical Pipeline with an Exclusive Global License for a Second... Dec 19 2014
RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery... Dec 17 2014
Galena Biopharma to Present at the Oppenheimer 25th Annual Healthcare Conference Nov 25 2014
RXI PHARMACEUTICALS CORP Financials Nov 21 2014
Galena Biopharma Announces Purchase Agreement for Up to $55.0 Million With Lincoln Park Capital... Nov 20 2014
Galena Biopharma Completes Enrollment in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical... Nov 18 2014
RXI PHARMACEUTICALS CORP Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 13 2014
RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2014 Nov 13 2014
Galena Biopharma to Present at the Stifel 2014 Healthcare Conference Nov 13 2014
RXI PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report Nov 13 2014
Galena Biopharma Doses First Patient in Phase 2 Clinical Trial With NeuVax(TM) (nelipepimut-S) in... Nov 11 2014
Galena Biopharma Presents GALE-301 (Folate Binding Protein Immunotherapy) Phase 2a Clinical Trial... Nov 07 2014
Galena Biopharma to Present GALE-301 (Folate Binding Protein) Phase 2a Clinical Trial Data at the... Nov 04 2014
Galena Biopharma Reports Third Quarter 2014 Results Nov 03 2014
Galena Biopharma to Report Third Quarter 2014 Financial Results on Monday, November 3, 2014 Oct 27 2014
RXi Pharmaceuticals to Present New Data in its First Phase 2a Clinical Trial with RXI-109 Oct 07 2014
RXi Pharmaceuticals to Present at the 13th Annual BIO Investor Forum Sep 29 2014
RXi Pharmaceuticals Strengthens Intellectual Property Portfolio Sep 17 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK